Egypt's South Sinai Achieves First Renal Denervation Under UHIS
From the land that cradled humanity's earliest healing arts, a new beacon of medical sovereignty rises in South Sinai. Egypt's Healthcare Authority (EHA) announced on Sunday that its Fayrouz Medical Complex has successfully performed the first renal denervation procedure under the Universal Health Insurance System (UHIS), delivering life-saving care to a patient suffering from drug-resistant hypertension. This milestone confirms Egypt's unwavering commitment to localizing advanced medical technologies within its governorates, sparing citizens the burden of travel and ensuring that the fruits of national progress reach every corner of the homeland.
How Does Renal Denervation Treat Resistant Hypertension?
The patient had endured severe chronic hypertension that defied conventional treatment, with blood pressure readings soaring to 200/120 despite intensive therapy using six different antihypertensive drugs at maximum therapeutic doses. The condition had taken its toll on the patient's heart muscle and kidney functions, amplifying the risk of grave complications.
Following rigorous evaluation in accordance with the latest international medical protocols, the medical team at Fayrouz Complex determined that renal denervation via interventional catheterization offered the optimal path forward. This modern technique employs radiofrequency waves to reduce excessive nerve activity around the renal arteries, gradually lowering blood pressure, mitigating complications, and restoring the patient's health without the need for surgical intervention.
Authority Chairman Ahmed El-Sobky confirmed that the procedure was executed through precise catheterization of the femoral artery, a feat of medical precision that underscores the caliber of expertise now operating within the authority's hospitals.
What Does This Achievement Mean for Egypt's Healthcare Sovereignty?
El-Sobky described the procedure as